Literature DB >> 19203262

Persistence of botulinum toxin in patients' serum: Alaska, 1959-2007.

Ryan P Fagan1, Joseph B McLaughlin, John P Middaugh.   

Abstract

Persistence of circulating toxin in patients with foodborne botulism is not well characterized. Recommendations for administration of botulinum antitoxin are ambiguous for patients with late-presenting disease, such as a Florida woman with toxin-positive serum 12 days after toxin ingestion. We reviewed Alaska records of foodborne outbreaks of botulism that occurred during 1959-2007 to examine the period after ingestion during which toxin was detected. Of 64 cases with toxin-positive serum, toxin was detected up to 11 days after ingestion. The findings from Alaska and Florida support administration of antitoxin up to 12 days after toxin ingestion but do not indicate when circulating toxin should no longer be present.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19203262     DOI: 10.1086/597310

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

Review 1.  Botulinum neurotoxins: genetic, structural and mechanistic insights.

Authors:  Ornella Rossetto; Marco Pirazzini; Cesare Montecucco
Journal:  Nat Rev Microbiol       Date:  2014-06-30       Impact factor: 60.633

2.  Embryonic stem cell-derived motoneurons provide a highly sensitive cell culture model for botulinum neurotoxin studies, with implications for high-throughput drug discovery.

Authors:  Erkan Kiris; Jonathan E Nuss; James C Burnett; Krishna P Kota; Dawn C Koh; Laura M Wanner; Edna Torres-Melendez; Rick Gussio; Lino Tessarollo; Sina Bavari
Journal:  Stem Cell Res       Date:  2011-01-19       Impact factor: 2.020

3.  The Novel Clostridial Neurotoxin Produced by Strain IBCA10-7060 Is Immunologically Equivalent to BoNT/HA.

Authors:  Yongfeng Fan; Jason R Barash; Fraser Conrad; Jianlong Lou; Christina Tam; Luisa W Cheng; Stephen S Arnon; James D Marks
Journal:  Toxins (Basel)       Date:  2019-12-20       Impact factor: 4.546

4.  Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type H.

Authors:  Yongfeng Fan; Jason R Barash; Jianlong Lou; Fraser Conrad; James D Marks; Stephen S Arnon
Journal:  J Infect Dis       Date:  2016-03-01       Impact factor: 5.226

5.  A Novel Inhibitor Prevents the Peripheral Neuroparalysis of Botulinum Neurotoxins.

Authors:  Domenico Azarnia Tehran; Giulia Zanetti; Oneda Leka; Florigio Lista; Silvia Fillo; Thomas Binz; Clifford C Shone; Ornella Rossetto; Cesare Montecucco; Cristina Paradisi; Andrea Mattarei; Marco Pirazzini
Journal:  Sci Rep       Date:  2015-12-16       Impact factor: 4.379

6.  Snake and Spider Toxins Induce a Rapid Recovery of Function of Botulinum Neurotoxin Paralysed Neuromuscular Junction.

Authors:  Elisa Duregotti; Giulia Zanetti; Michele Scorzeto; Aram Megighian; Cesare Montecucco; Marco Pirazzini; Michela Rigoni
Journal:  Toxins (Basel)       Date:  2015-12-08       Impact factor: 4.546

7.  Endocytosis, trafficking and exocytosis of intact full-length botulinum neurotoxin type a in cultured rat neurons.

Authors:  Luis Solabre Valois; Kevin A Wilkinson; Yasuko Nakamura; Jeremy M Henley
Journal:  Neurotoxicology       Date:  2020-02-20       Impact factor: 4.294

Review 8.  Toxemia in Human Naturally Acquired Botulism.

Authors:  Christine Rasetti-Escargueil; Emmanuel Lemichez; Michel R Popoff
Journal:  Toxins (Basel)       Date:  2020-11-13       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.